As of Feb 20, 2025, Apple Relative Value is $4.3. This suggests it may be overvalued by 45.9% compared to its current price of around $7.9.
As of Feb 20, 2025, LifeStance Health Group, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $7.9, using a discount rate of 8.9% and terminal growth rate of 3.0%.
As of Feb 20, 2025, Apple Intrinsic Value is $4.3. This suggests it may be overvalued by 45.6% compared to its current price of around $7.9.